CJMB Callan JMB Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
11:15
Mar 22
Mar 22
CJMB long on GLP-1 cold-chain pivot
The author is very bullish on CJMB because it is pivoting to cold-chain infrastructure and vertically integrated manufacturing for the rapidly growing GLP-1 and peptide market, serving telehealth providers of these sensitive drugs. The catalyst is the strategic pivot and retrofitting of a Texas cGMP facility, which the author calls selling shovels in a gold rush. The main stated risks are that the company is not profitable, there is significant risk of capital raises/dilution, and revenue growth depends on catalysts and execution.
HIGH
13:24
Jan 12
Jan 12
Deep-value cold-chain logistics with insider buying and M&A optionality
Author argues Callan JMB is a deep value play trading near $1.15, with ~$4.2M cash against a ~$5.2M market cap and a $9.1M Chicago emergency supplies contract through June 2026, plus December 2025 insider buys at $1.65-$1.75. Catalysts include GLP-1 cold-chain logistics demand, Texas manufacturing facility deployment updates, the February 11, 2026 quarterly earnings, and possible M&A buyout at $3.50-$5.00 per share. The author's near-term targets are $1.80-$2.50 in 1-2 weeks and $3.00-$4.20 in 4-5 weeks if revenue beats or GLP-1 contract wins occur.
HIGH
About CJMB Investor Commentary
Across the available history and selected sources, Buzzberg tracks CJMB (Callan JMB Inc.) across 2 sources: 2 bullish vs 0 bearish calls from 2 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 2 total trade ideas tracked. Latest voices: u/Yung_Ceejay, u/Familiar_Potato1244.